These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7502867)

  • 1. Aerosol treatment of pigs with Actinobacillus pleuropneumoniae serotype 2: mucosal immunity and resistance against challenge.
    Loftager MK; Eriksen L; Nielsen R
    Adv Exp Med Biol; 1995; 371B():1611-4. PubMed ID: 7502867
    [No Abstract]   [Full Text] [Related]  

  • 2. Mucosal and serum IgA antibodies in pigs following infection with Actinobacillus pleuropneumoniae.
    Loftager MK; Eriksen L; Nielsen R
    Adv Exp Med Biol; 1995; 371B():935-8. PubMed ID: 7502930
    [No Abstract]   [Full Text] [Related]  

  • 3. Protective immunity following immunisation of pigs with aerosol of Actinobacillus pleuropneumoniae serotype 2.
    Loftager MK; Eriksen L; Aasted B; Nielsen R
    Res Vet Sci; 1993 Nov; 55(3):281-6. PubMed ID: 8284489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral immunization with lung-pathogenic bacteria is protective against defined challenge in a pig aerosol infection model.
    Hensel A; Delventhal S; Windt H; Stockhofe-Zurwieden N; Pabst R; Petzoldt K
    Adv Exp Med Biol; 1995; 371B():803-6. PubMed ID: 7502901
    [No Abstract]   [Full Text] [Related]  

  • 5. Aerosol exposure of pigs to viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces antibodies in bronchoalveolar lining fluids and serum, and protects against homologous challenge.
    Hensel A; Stockhofe-Zurwieden N; Ganter M; Petzoldt K
    Vet Microbiol; 1995 Nov; 47(1-2):27-41. PubMed ID: 8604553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induction of polyvalent immunity against Actinobacillus pleuropneumoniae in an experimental rat model].
    Herrera L; Montiel E; Rosales ME; Bárcenas G; Lara AV; Montaraz JA
    Rev Latinoam Microbiol; 1995; 37(2):147-52. PubMed ID: 8552874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccine encoding type IV pilin of Actinobacillus pleuropneumoniae induces strong immune response but confers limited protective efficacy against serotype 2 challenge.
    Lu YC; Li MC; Chen YM; Chu CY; Lin SF; Yang WJ
    Vaccine; 2011 Oct; 29(44):7740-6. PubMed ID: 21835218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against Actinobacillus pleuropneumoniae serotype 2 in mucosal secretions and sera of infected pigs as demonstrated by an enzyme-linked immunosorbent assay.
    Loftager MK; Eriksen L; Nielsen R
    Res Vet Sci; 1993 Jan; 54(1):57-62. PubMed ID: 8434149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model.
    Seo KW; Kim SH; Park J; Son Y; Yoo HS; Lee KY; Jang YS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):102-12. PubMed ID: 23200821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity.
    Dubreuil JD; Jacques M; Mittal KR; Gottschalk M
    Anim Health Res Rev; 2000 Dec; 1(2):73-93. PubMed ID: 11708600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a saline boiled extract, capsular polysaccharides and long-chain lipopolysaccharides of Actinobacillus pleuropneumoniae serotype 1 as antigens for the serodiagnosis of swine pleuropneumonia.
    Gottschalk M; Altman E; Charland N; De Lasalle F; Dubreuil JD
    Vet Microbiol; 1994 Nov; 42(2-3):91-104. PubMed ID: 7886937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia.
    Haga Y; Ogino S; Ohashi S; Ajito T; Hashimoto K; Sawada T
    J Vet Med Sci; 1997 Feb; 59(2):115-20. PubMed ID: 9070983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
    Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
    Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the role of antibodies to Actinobacillus pleuropneumoniae serovar 1 and 15 in the protection provided by sub-unit and live streptomycin-dependent pleuropneumonia vaccines.
    Tumamao JQ; Bowles RE; van den Bosch H; Klaasen HL; Fenwick BW; Blackall PJ
    Aust Vet J; 2004 Dec; 82(12):773-80. PubMed ID: 15648941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses.
    Katinger A; Lubitz W; Szostak MP; Stadler M; Klein R; Indra A; Huter V; Hensel A
    J Biotechnol; 1999 Aug; 73(2-3):251-60. PubMed ID: 10486934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral immunization of pigs with viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces pulmonary and systemic antibodies and protects against homologous aerosol challenge.
    Hensel A; Stockhofe-Zurwieden N; Petzoldt K; Lubitz W
    Infect Immun; 1995 Aug; 63(8):3048-53. PubMed ID: 7622229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization by the enteral and respiratory route with viable and inactivated bacteria results in a differential increase in lymphocyte subsets in the bronchoalveolar space.
    Pabst R; Delventhal S; Hensel A; Petzoldt K
    Adv Exp Med Biol; 1995; 371B():1459-61. PubMed ID: 7502837
    [No Abstract]   [Full Text] [Related]  

  • 18. Protective effect of the combined vaccine prepared from cell-free-antigen of Actinobacillus pleuropneumoniae serotypes 1, 2 and 5 in pigs.
    Oishi E; Kitajima T; Koyama Y; Ohgitani T; Katayama S; Okabe T
    J Vet Med Sci; 1995 Dec; 57(6):1125-8. PubMed ID: 8720063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-protection between Actinobacillus pleuropneumoniae biotypes-serotypes in pigs.
    Haesebrouk F; Van de Kerkhof A; Dom P; Chiers K; Ducatelle R
    Vet Microbiol; 1996 Oct; 52(3-4):277-84. PubMed ID: 8972053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.
    Zhang F; Zhao Q; Quan K; Zhu Z; Yang Y; Wen X; Chang YF; Huang X; Wu R; Wen Y; Yan Q; Huang Y; Ma X; Han X; Cao S
    PLoS One; 2018; 13(6):e0198207. PubMed ID: 29856812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.